UBS AM
FBT icon

UBS AM’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

UBS AM’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1K Sell
89
-50
-36% -$10.8K ﹤0.01% 3110
2026
Q1 		$27.9K Buy
139
+89
+178% +$18.4K ﹤0.01% 3078
2025
Q4 		$10.3K Buy
+50
New +$9.99K ﹤0.01% 2849

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

UBS AM's FBT Position: Q2 2026 in Review

UBS AM reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 36% in Q2 2026, selling an estimated $10.8K and leaving 89 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3110.

UBS AM first reported a position in FBT in Q4 2025 and has held it in 3 quarters since. The position peaked at $27.9K in Q1 2026. 338 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • UBS AM held 89 shares of First Trust NYSE Arca Biotechnology Index Fund worth $22.1K as of Q2 2026.
  • UBS AM sold 50 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $10.8K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #3110 holding.
  • UBS AM first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2025 and has held it in 3 quarters since.
  • UBS AM's First Trust NYSE Arca Biotechnology Index Fund position peaked at $27.9K in Q1 2026.
  • 338 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.